Precise CRISPR-Mediated Editing of the TGFBI R555W Mutation in Patient-Derived Peripheral Blood Mononuclear Cells
International Journal of Molecular Sciences · 06.03.2026 · 27 (5) · 2418
DOI: 10.3390/ijms27052418 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2026. Verfasst von Burak Dagdelen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Selçuk University, 42130 Konya, Türkiye. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Corneal Dystrophies, Hereditary, Gene Editing, Transforming Growth Factor beta. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Selçuk University.
Abstract (Originalsprache)
Over 70 mutations in the transforming growth factor beta-induced (TGFBI) gene are associated with corneal dystrophies that impair vision. The R555W hotspot mutation is a major cause of granular corneal dystrophy type 1 (GCD1). Here, we evaluated the technical feasibility of CRISPR/Cas9-mediated editing of the R555W mutation in peripheral blood mononuclear cells (PBMCs) obtained from a patient with GCD1. Three single guide RNAs (sgRNA1–3) and matched single-stranded oligodeoxynucleotide donors (ssODN1–3) were designed and co-transfected into PBMCs. Transfected cells were enriched by flow cytometric sorting, with GFP-positive cells representing approximately 2–4% of the total electroporated population. Editing outcomes were initially screened using high-resolution melting (HRM) analysis, and the sgRNA3–ssODN3 combination identified as the most promising candidate was subsequently validated by next-generation sequencing (NGS). Sequencing revealed a homology-directed repair efficiency of 98.2% among GFP-positive sorted cells, demonstrating efficient and precise genome editing within the enriched population. Because PBMCs are not disease-relevant corneal epithelial cells and only genomic endpoints were assessed, the clinical applicability of this study is limited and the work should be considered a technical proof-of-concept. This framework supports optimization of CRISPR-based strategies prior to studies in biologically relevant corneal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Selçuk University, 42130 Konya, Türkiye.
- Department of Ophthalmology, Faculty of Medicine, Selçuk University, 42130 Konya, Türkiye.
ORCID-Profile: Burak Dagdelen, Hilal Arikoglu, Banu Bozkurt
Förderung
- Selçuk University
Zitieren
APA
Dagdelen, B., Arikoglu, H., Erkoc-Kaya, D., & Bozkurt, B. (2026). Precise CRISPR-Mediated Editing of the TGFBI R555W Mutation in Patient-Derived Peripheral Blood Mononuclear Cells. International Journal of Molecular Sciences, 27(5), 2418. https://doi.org/10.3390/ijms27052418
Vancouver
Dagdelen B, Arikoglu H, Erkoc-Kaya D, Bozkurt B. Precise CRISPR-Mediated Editing of the TGFBI R555W Mutation in Patient-Derived Peripheral Blood Mononuclear Cells. International Journal of Molecular Sciences. 2026;27(5):2418. doi:10.3390/ijms27052418
BibTeX
@article{Dagdelen2026,
author = {Dagdelen, Burak and Arikoglu, Hilal and Erkoc-Kaya, Dudu and Bozkurt, Banu},
title = {Precise CRISPR-Mediated Editing of the TGFBI R555W Mutation in Patient-Derived Peripheral Blood Mononuclear Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2418},
doi = {10.3390/ijms27052418}
}
EUVIMED